Android app on Google Play

Baird Upgrades Endocyte (ECYT) to Outperform

March 25, 2013 7:19 AM EDT Send to a Friend
Get Alerts ECYT Hot Sheet
Price: $7.26 -4.97%

Rating Summary:
    9 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 21
Trade ECYT Now!
Join SI Premium – FREE
Baird upgraded Endocyte (NASDAQ: ECYT) from Neutral to Outperform with a price target of $13.00 (from $9.00).

For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.

Shares of Endocyte closed at $10.03 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades

Related Entities

Robert W Baird

Add Your Comment